{
  "refGenomeVersion": "V37",
  "serveVersion": "local-SNAPSHOT",
  "knownEvents": {
    "hotspots": [
      {
        "inputTranscript": "trans1",
        "inputProteinAnnotation": "F1389S",
        "gene": "CREBBP",
        "ref": "GA",
        "alt": "TG",
        "chromosome": "16",
        "position": 3789692,
        "geneRole": "BOTH",
        "proteinEffect": "UNKNOWN",
        "associatedWithDrugResistance": false,
        "sources": [
          "VICC_CGI"
        ]
      },
      {
        "inputProteinAnnotation": "C124*",
        "gene": "TP53",
        "ref": "G",
        "alt": "T",
        "chromosome": "17",
        "position": 7579315,
        "geneRole": "TSG",
        "proteinEffect": "LOSS_OF_FUNCTION_PREDICTED",
        "sources": [
          "VICC_CGI"
        ]
      }
    ],
    "codons": [
      {
        "inputTranscript": "ENST00000369535",
        "inputCodonRank": 179,
        "gene": "NRAS",
        "applicableMutationType": "MISSENSE",
        "chromosome": "1",
        "start": 115251189,
        "end": 115251191,
        "geneRole": "ONCO",
        "proteinEffect": "GAIN_OF_FUNCTION",
        "associatedWithDrugResistance": false,
        "sources": [
          "VICC_CIVIC"
        ]
      },
      {
        "inputTranscript": "ENST00000369535",
        "inputCodonRank": 61,
        "gene": "NRAS",
        "applicableMutationType": "MISSENSE",
        "chromosome": "1",
        "start": 115256528,
        "end": 115256530,
        "geneRole": "ONCO",
        "proteinEffect": "GAIN_OF_FUNCTION",
        "sources": [
          "VICC_CGI",
          "VICC_CIVIC"
        ]
      }
    ],
    "exons": [
      {
        "inputTranscript": "ENST00000263967",
        "inputExonRank": 10,
        "gene": "PIK3CA",
        "applicableMutationType": "MISSENSE",
        "chromosome": "3",
        "start": 178935993,
        "end": 178936127,
        "geneRole": "ONCO",
        "proteinEffect": "GAIN_OF_FUNCTION",
        "sources": [
          "VICC_CIVIC"
        ]
      },
      {
        "inputTranscript": "ENST00000263967",
        "inputExonRank": 21,
        "gene": "PIK3CA",
        "applicableMutationType": "MISSENSE",
        "chromosome": "3",
        "start": 178951877,
        "end": 178957886,
        "geneRole": "ONCO",
        "proteinEffect": "GAIN_OF_FUNCTION",
        "associatedWithDrugResistance": true,
        "sources": [
          "VICC_CIVIC"
        ]
      }
    ],
    "genes": [
      {
        "gene": "NRAS",
        "geneRole": "ONCO",
        "sources": [
          "VICC_CIVIC"
        ]
      }
    ],
    "copyNumbers": [
      {
        "gene": "NF1",
        "event": "DELETION",
        "geneRole": "TSG",
        "proteinEffect": "LOSS_OF_FUNCTION",
        "sources": [
          "VICC_CIVIC"
        ]
      },
      {
        "gene": "SND1",
        "event": "OVEREXPRESSION",
        "geneRole": "ONCO",
        "proteinEffect": "NO_EFFECT",
        "associatedWithDrugResistance": true,
        "sources": [
          "VICC_CIVIC"
        ]
      }
    ],
    "fusions": [
      {
        "proteinEffect": "UNKNOWN",
        "geneUp": "ABCC4",
        "geneDown": "ETV4",
        "sources": [
          "VICC_CIVIC"
        ]
      },
      {
        "proteinEffect": "GAIN_OF_FUNCTION",
        "associatedWithDrugResistance": true,
        "geneUp": "KIT",
        "minExonUp": 11,
        "maxExonUp": 11,
        "geneDown": "KIT",
        "minExonDown": 11,
        "maxExonDown": 11,
        "sources": [
          "VICC_CGI"
        ]
      }
    ]
  },
  "actionableEvents": {
    "hotspots": [
      {
        "gene": "BRAF",
        "ref": "A",
        "alt": "T",
        "chromosome": "7",
        "position": 140453136,
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 3
        },
        "sourceEvent": "variant",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Vemurafenib",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Skin Melanoma",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "gene": "BRAF",
        "ref": "A",
        "alt": "T",
        "chromosome": "7",
        "position": 140453137,
        "source": "CKB_TRIAL",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "variant",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "ClinicalTrial",
          "nctId": "NCT1",
          "title": "study1",
          "acronym": "study11",
          "countries": [
            {
              "countryName": "Netherlands",
              "hospitalsPerCity": {
                "Maastricht": [
                  "MUMC"
                ],
                "Nijmegen": [
                  "Radboud UMC"
                ]
              }
            }
          ],
          "therapyNames": [
            "Vemurafenib"
          ],
          "genderCriterium": "female"
        },
        "applicableCancerType": {
          "name": "Solid tumor",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "",
        "evidenceYear": 2024,
        "evidenceLevel": "C",
        "evidenceLevelDetails": "CLINICAL_STUDY",
        "direction": "RESISTANT",
        "evidenceUrls": [
          "http"
        ]
      }
    ],
    "codons": [
      {
        "gene": "BRAF",
        "applicableMutationType": "MISSENSE",
        "chromosome": "7",
        "start": 140453136,
        "end": 140453137,
        "source": "CKB_TRIAL",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "600X",
        "sourceUrls": [
          "NCT1"
        ],
        "intervention": {
          "type": "ClinicalTrial",
          "nctId": "study1",
          "title": "study1",
          "countries": [
            {
              "countryName": "Netherlands",
              "hospitalsPerCity": {
                "Rotterdam": [
                  "EMC"
                ]
              }
            }
          ],
          "therapyNames": [
            "Vemurafenib"
          ]
        },
        "applicableCancerType": {
          "name": "Breast cancer",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "gene": "BRAF",
        "applicableMutationType": "MISSENSE",
        "chromosome": "7",
        "start": 140453136,
        "end": 140453137,
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 3
        },
        "sourceEvent": "600X",
        "sourceUrls": [],
        "intervention": {
          "type": "Treatment",
          "name": "Vemurafenib",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Skin Melanoma",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      }
    ],
    "exons": [
      {
        "gene": "EGFR",
        "applicableMutationType": "INFRAME",
        "chromosome": "7",
        "start": 55241707,
        "end": 55279321,
        "source": "CKB_TRIAL",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "exon 21",
        "sourceUrls": [],
        "intervention": {
          "type": "ClinicalTrial",
          "nctId": "NCT1",
          "title": "study1",
          "countries": [
            {
              "countryName": "Belgium",
              "hospitalsPerCity": {
                "Brussel": [
                  "UZ Brussel"
                ]
              }
            }
          ],
          "therapyNames": [
            "Erlotinib"
          ]
        },
        "applicableCancerType": {
          "name": "Pancreas",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESISTANT",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "gene": "EGFR",
        "applicableMutationType": "INFRAME",
        "chromosome": "7",
        "start": 55241707,
        "end": 55279321,
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "exon 21",
        "sourceUrls": [],
        "intervention": {
          "type": "Treatment",
          "name": "Erlotinib",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Lung Adeno",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESISTANT",
        "evidenceUrls": [
          "http"
        ]
      }
    ],
    "genes": [
      {
        "gene": "ALK",
        "event": "FUSION",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 3
        },
        "sourceEvent": "fusion",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Crizotinib",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Lung Adenocarcinoma",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence A",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "https"
        ]
      },
      {
        "gene": "BRCA1",
        "event": "INACTIVATION",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 4
        },
        "sourceEvent": "inact",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "DRUP",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Solid Tumors",
          "doid": "X"
        },
        "blacklistCancerTypes": [
          {
            "name": "Hematologic cancer",
            "doid": "2531"
          }
        ],
        "efficacyDescription": "efficacy evidence B",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "gene": "ERBB2",
        "event": "AMPLIFICATION",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 5
        },
        "sourceEvent": "amp",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Trastuzumab",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Breast Cancer",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence C",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "gene": "ERBB2",
        "event": "AMPLIFICATION",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 6
        },
        "sourceEvent": "amp",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Panitumumab",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Colorectal Cancer",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence D",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESISTANT",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "gene": "FGFR2",
        "event": "FUSION",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 7
        },
        "sourceEvent": "fusion",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Erdafitinib",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Bladder Cancer",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence E",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": []
      },
      {
        "gene": "MET",
        "event": "AMPLIFICATION",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 8
        },
        "sourceEvent": "amp",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "DRUP",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Advanced Solid Tumor",
          "doid": "X"
        },
        "blacklistCancerTypes": [
          {
            "name": "Hematologic cancer",
            "doid": "2531"
          }
        ],
        "efficacyDescription": "efficacy evidence F",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": []
      },
      {
        "gene": "NRAS",
        "event": "ACTIVATION",
        "source": "CKB_TRIAL",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "act",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "ClinicalTrial",
          "nctId": "NCT1",
          "title": "study1",
          "acronym": "study1",
          "countries": [
            {
              "countryName": "Belgium",
              "hospitalsPerCity": {
                "Antwerpen": [
                  "ZAS Vincentius"
                ]
              }
            }
          ],
          "therapyNames": [
            "Cetuximab"
          ],
          "genderCriterium": "male"
        },
        "applicableCancerType": {
          "name": "Colorectal Cancer",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESISTANT",
        "evidenceUrls": [
          "http"
        ]
      }
    ],
    "fusions": [
      {
        "geneUp": "EGFR",
        "minExonUp": 1,
        "maxExonUp": 2,
        "geneDown": "EGFR",
        "minExonDown": 8,
        "maxExonDown": 9,
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 3
        },
        "sourceEvent": "fusion",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Osimertinib",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Lung Cancer",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence A",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "geneUp": "EML4",
        "geneDown": "ALK",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 4
        },
        "sourceEvent": "fusion",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Crizotinib",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "Lung Cancer",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "efficacy evidence B",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "geneUp": "PCM1",
        "geneDown": "JAK2",
        "source": "CKB_TRIAL",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "fusion",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "ClinicalTrial",
          "nctId": "NCT1",
          "title": "study1",
          "acronym": "study1",
          "countries": [
            {
              "countryName": "Germany",
              "hospitalsPerCity": {
                "Frankfurt": [
                  "Burgerhospital Frankfurt"
                ],
                "Koln": [
                  "Cellitinnen-Krankenhaus St. Marien"
                ]
              }
            }
          ],
          "therapyNames": [
            "Ruxolitinib"
          ],
          "genderCriterium": "male"
        },
        "applicableCancerType": {
          "name": "Leukemia",
          "doid": "X"
        },
        "blacklistCancerTypes": [],
        "efficacyDescription": "",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      }
    ],
    "characteristics": [
      {
        "type": "MICROSATELLITE_UNSTABLE",
        "cutoffType": "EQUAL_OR_GREATER",
        "cutoff": 4.0,
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 3
        },
        "sourceEvent": "msi",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Nivolumab",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "All cancer types",
          "doid": "X"
        },
        "blacklistCancerTypes": [
          {
            "name": "Hematologic cancer",
            "doid": "2531"
          }
        ],
        "efficacyDescription": "efficacy evidence",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http1",
          "http2"
        ]
      },
      {
        "type": "MICROSATELLITE_UNSTABLE",
        "source": "CKB_TRIAL",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "msi",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "ClinicalTrial",
          "nctId": "NCT1",
          "title": "study1",
          "countries": [
            {
              "countryName": "Belgium",
              "hospitalsPerCity": {
                "Brussel": [
                  "UZ Brussel"
                ]
              }
            },
            {
              "countryName": "Netherlands",
              "hospitalsPerCity": {
                "Eindhoven": [
                  "Catharina"
                ],
                "Rotterdam": [
                  "EMC"
                ]
              }
            }
          ],
          "therapyNames": [
            "Immuno",
            "Pembro"
          ],
          "genderCriterium": "both"
        },
        "applicableCancerType": {
          "name": "All cancer types",
          "doid": "X"
        },
        "blacklistCancerTypes": [
          {
            "name": "Hematologic cancer",
            "doid": "2531"
          }
        ],
        "efficacyDescription": "",
        "evidenceYear": 2024,
        "evidenceLevel": "B",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http3",
          "http4"
        ]
      }
    ],
    "hla": [
      {
        "hlaAllele": "A*02",
        "source": "CKB_TRIAL",
        "entryDate": {
          "year": 1970,
          "month": 1,
          "day": 1
        },
        "sourceEvent": "A*02",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "ClinicalTrial",
          "nctId": "NCT1",
          "title": "study1",
          "acronym": "study1",
          "countries": [
            {
              "countryName": "Netherlands",
              "hospitalsPerCity": {
                "Groningen": [
                  "UMCG"
                ],
                "Utrecht": [
                  "UMCU"
                ]
              }
            }
          ],
          "therapyNames": [
            "Nivolumab"
          ],
          "genderCriterium": "female"
        },
        "applicableCancerType": {
          "name": "Skin melanoma",
          "doid": "X"
        },
        "blacklistCancerTypes": [
          {
            "name": "Hematologic cancer",
            "doid": "2531"
          }
        ],
        "efficacyDescription": "",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      },
      {
        "hlaAllele": "A*02",
        "source": "CKB_EVIDENCE",
        "entryDate": {
          "year": 2021,
          "month": 2,
          "day": 3
        },
        "sourceEvent": "A*02",
        "sourceUrls": [
          "http"
        ],
        "intervention": {
          "type": "Treatment",
          "name": "Nivolumab",
          "treatmentApproachesDrugClass": [],
          "treatmentApproachesTherapy": []
        },
        "applicableCancerType": {
          "name": "All cancer types",
          "doid": "X"
        },
        "blacklistCancerTypes": [
          {
            "name": "Hematologic cancer",
            "doid": "2531"
          }
        ],
        "efficacyDescription": "efficacy evidence",
        "evidenceYear": 2024,
        "evidenceLevel": "A",
        "evidenceLevelDetails": "GUIDELINE",
        "direction": "RESPONSIVE",
        "evidenceUrls": [
          "http"
        ]
      }
    ]
  }
}
